{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:45:19Z","timestamp":1779338719690,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172129"],"award-info":[{"award-number":["81172129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472798"],"award-info":[{"award-number":["81472798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703030"],"award-info":[{"award-number":["81703030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.humpath.2018.03.011","type":"journal-article","created":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T00:53:09Z","timestamp":1521247989000},"page":"58-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Aberrant high expression level of MORC2 is a common character in multiple cancers"],"prefix":"10.1016","volume":"76","author":[{"given":"Qian-shan","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi-cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-qiong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-bo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian-lian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-gang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.03.011_bb0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4161\/epi.24976","article-title":"The MORC family: new epigenetic regulators of transcription and DNA damage response","volume":"8","author":"Li","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.humpath.2018.03.011_bb0010","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.1221472","article-title":"MORC family ATPases required for heterochromatin condensation and gene silencing","author":"Moissiard","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.humpath.2018.03.011_bb0015","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/ar.21119","article-title":"Identification and expression analysis of a novel CW-type zinc finger protein MORC2 in cancer cells","volume":"293","author":"Wang","year":"2010","journal-title":"Anat Rec (Hoboken)"},{"key":"10.1016\/j.humpath.2018.03.011_bb0020","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41467-018-03045-x","article-title":"Neuropathic MORC2 mutations perturb GHKL ATPase dimerization dynamics and epigenetic silencing by multiple structural mechanisms","volume":"9","author":"Douse","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2018.03.011_bb0025","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ng.3878","article-title":"Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2","volume":"49","author":"Tchasovnikarova","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2018.03.011_bb0030","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1093\/brain\/aww252","article-title":"MORC2 mutation causes severe spinal muscular atrophy-phenotype, cerebellar atrophy, and diaphragmatic paralysis","volume":"139","author":"Schottmann","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.humpath.2018.03.011_bb0035","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/nar\/gkq006","article-title":"Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX","volume":"38","author":"Shao","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.humpath.2018.03.011_bb0040","doi-asserted-by":"crossref","first-page":"16461","DOI":"10.18632\/oncotarget.3889","article-title":"By recruiting HDAC1, MORC2 suppresses p21 Waf1\/Cip1 in gastric cancer","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.03.011_bb0045","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.18632\/oncotarget.3185","article-title":"PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.03.011_bb0050","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbamcr.2013.11.012","article-title":"Cytosolic functions of MORC2 in lipogenesis and adipogenesis","volume":"1843","author":"S\u00e1nchez-Solana","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.humpath.2018.03.011_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028222","article-title":"Identification of prognostic genes for recurrent risk prediction in triple negative breast cancer patients in Taiwan","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2018.03.011_bb0060","first-page":"1104","article-title":"HSF1, in association with MORC2, downregulates ArgBP2 via the PRC2 family in gastric cancer cells","volume":"2018","author":"Tong","year":"1864","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.humpath.2018.03.011_bb0065","doi-asserted-by":"crossref","first-page":"97941","DOI":"10.18632\/oncotarget.18556","article-title":"Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain\u2013mediated interaction with CTNND1","volume":"8","author":"Liao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.03.011_bb0070","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/jcp.25665","article-title":"The emerging role of MORC family proteins in cancer development and bone homeostasis","volume":"232","author":"Hong","year":"2017","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.humpath.2018.03.011_bb0075","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbrc.2015.10.059","article-title":"Microchidia protein 2, MORC2, downregulates the cytoskeleton adapter protein, ArgBP2, via histone methylation in gastric cancer cells","volume":"467","author":"Tong","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.humpath.2018.03.011_bb0080","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.celrep.2012.11.018","article-title":"MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response","author":"Li","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.humpath.2018.03.011_bb0085","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2018.03.011_bb0090","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2018.03.011_bb0095","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3892\/ijo.2014.2441","article-title":"Lipogenesis in cancer progression (review)","volume":"45","author":"Mounier","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.humpath.2018.03.011_bb0100","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2018.03.011_bb0105","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.molcel.2013.07.002","article-title":"Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth","volume":"51","author":"Lin","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.humpath.2018.03.011_bb0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/B978-0-12-800255-1.00007-7","article-title":"Role of p-21\u2013activated kinases in cancer progression","volume":"309","author":"King","year":"2014","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.humpath.2018.03.011_bb0115","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1158\/1078-0432.CCR-11-1952","article-title":"Molecular pathways: targeting p21-activated kinase 1 signaling in cancer\u2014opportunities, challenges, and limitations","volume":"18","author":"Eswaran","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.03.011_bb0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ccr.2004.11.004","article-title":"Somatic alterations in the human cancer genome","author":"Weir","year":"2004","journal-title":"Cancer Cell"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718300881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718300881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T23:15:02Z","timestamp":1617837302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817718300881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":24,"alternative-id":["S0046817718300881"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.03.011","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant high expression level of MORC2 is a common character in multiple cancers","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}